Wall Street brokerages expect Integer Holdings Corp (NYSE:ITGR) to announce $1.06 earnings per share for the current quarter, Zacks reports. Two analysts have made estimates for Integer’s earnings, with estimates ranging from $1.05 to $1.06. Integer also posted earnings of $1.06 per share during the same quarter last year. The firm is expected to report its next earnings report on Thursday, August 1st.

According to Zacks, analysts expect that Integer will report full-year earnings of $4.30 per share for the current year, with EPS estimates ranging from $4.25 to $4.34. For the next fiscal year, analysts forecast that the company will report earnings of $4.84 per share, with EPS estimates ranging from $4.75 to $4.92. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that follow Integer.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, May 2nd. The medical equipment provider reported $1.00 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.80 by $0.20. The business had revenue of $314.70 million for the quarter, compared to analysts’ expectations of $302.29 million. Integer had a return on equity of 13.37% and a net margin of 14.67%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.61 EPS.

ITGR has been the topic of several analyst reports. ValuEngine lowered shares of Integer from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Zacks Investment Research downgraded shares of Integer from a “buy” rating to a “hold” rating in a research note on Monday, January 21st. Finally, Royal Bank of Canada upped their target price on shares of Integer from $84.00 to $92.00 and gave the company a “sector perform” rating in a report on Monday, February 25th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $89.40.

In related news, insider Jose Antonio Gonzalez sold 9,088 shares of the company’s stock in a transaction that occurred on Thursday, February 28th. The shares were sold at an average price of $90.88, for a total value of $825,917.44. Following the completion of the sale, the insider now owns 11,899 shares in the company, valued at approximately $1,081,381.12. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Anthony W. Borowicz sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $85.92, for a total transaction of $214,800.00. Following the completion of the sale, the senior vice president now owns 18,124 shares of the company’s stock, valued at approximately $1,557,214.08. The disclosure for this sale can be found here. In the last 90 days, insiders sold 62,147 shares of company stock valued at $5,358,962. 2.24% of the stock is owned by insiders.

Several large investors have recently modified their holdings of ITGR. Optimum Investment Advisors acquired a new position in Integer in the 1st quarter valued at approximately $30,000. Robeco Institutional Asset Management B.V. acquired a new position in shares of Integer during the 1st quarter worth $40,000. Financial Gravity Wealth Inc. acquired a new position in shares of Integer during the 1st quarter worth $45,000. Financial Gravity Companies Inc. acquired a new position in shares of Integer during the 4th quarter worth $49,000. Finally, Macquarie Group Ltd. increased its stake in shares of Integer by 36.8% during the 1st quarter. Macquarie Group Ltd. now owns 684 shares of the medical equipment provider’s stock worth $52,000 after purchasing an additional 184 shares during the last quarter. Institutional investors and hedge funds own 93.84% of the company’s stock.

Shares of Integer stock opened at $69.00 on Friday. The company has a market cap of $2.31 billion, a PE ratio of 18.16 and a beta of 0.91. Integer has a 1-year low of $62.80 and a 1-year high of $92.61. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.49 and a current ratio of 2.55.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Featured Article: Asset Allocation, Balancing Your Investments

Get a free copy of the Zacks research report on Integer (ITGR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.